![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1445.jpg)
Intra-operative electrons: ELIOT trial
•
ELIOT system : single dose 21Gy intra-operative electrons
immediately post-operatively pioneered in Milan
•
RCT of breast EBRT vs. ELIOT shows higher local cancer
recurrence with ELIOT
•
EBRT 5 year recurrence 0.4%
•
ELIOT 5 year recurrence 4.4%
•
Only recommended in clinical trials with small tumours
•
Veronesi et al. Lancet Oncology (2013) 14: 1269